| Style | Citing Format |
|---|---|
| MLA | Soltani S, et al.. "A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran." BMC Public Health, vol. 23, no. 1, 2023, pp. -. |
| APA | Soltani S, Matin BK, Gouya MM, Zahraei SM, Moradi G, Chehri O, Soofi M, Moradinazar M, Shadmani FK, Kalantari M, Khajeha H, Emamian MH, Najafi F (2023). A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran. BMC Public Health, 23(1), -. |
| Chicago | Soltani S, Matin BK, Gouya MM, Zahraei SM, Moradi G, Chehri O, Soofi M, et al.. "A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran." BMC Public Health 23, no. 1 (2023): -. |
| Harvard | Soltani S et al. (2023) 'A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran', BMC Public Health, 23(1), pp. -. |
| Vancouver | Soltani S, Matin BK, Gouya MM, Zahraei SM, Moradi G, Chehri O, et al.. A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran. BMC Public Health. 2023;23(1):-. |
| BibTex | @article{ author = {Soltani S and Matin BK and Gouya MM and Zahraei SM and Moradi G and Chehri O and Soofi M and Moradinazar M and Shadmani FK and Kalantari M and Khajeha H and Emamian MH and Najafi F}, title = {A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran}, journal = {BMC Public Health}, volume = {23}, number = {1}, pages = {-}, year = {2023} } |
| RIS | TY - JOUR AU - Soltani S AU - Matin BK AU - Gouya MM AU - Zahraei SM AU - Moradi G AU - Chehri O AU - Soofi M AU - Moradinazar M AU - Shadmani FK AU - Kalantari M AU - Khajeha H AU - Emamian MH AU - Najafi F TI - A Prospective Cohort Study Protocol: Monitoring and Surveillance of Adverse Events Following Heterologous Booster Doses of Oxford Astrazeneca Covid-19 Vaccine in Previous Recipients of Two Doses of Sinopharm or Sputnik V Vaccines in Iran JO - BMC Public Health VL - 23 IS - 1 SP - EP - PY - 2023 ER - |